Filing Flows › BioXcel Therapeutics (BTAIQ) › How it makes money
How BioXcel Therapeutics (BTAIQ) makes money
BioXcel Therapeutics (BTAIQ) made $182K of revenue in the second quarter 2026 (Q2 2026), +52% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $182K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $182K | +52% |
| Q1 2026 | $206K | +23% |
| Q4 2025 | $256K | -30% |
| Q3 2025 | $98K | -54% |
| Q2 2025 | $120K | -89% |
| Q1 2025 | $168K | -71% |
| Q4 2024 | $366K | -3% |
From BioXcel Therapeutics' 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does BioXcel Therapeutics make money?
BioXcel Therapeutics (BTAIQ) made $182K of revenue in the second quarter 2026 (Q2 2026), +52% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.